Document is current

Article History

Accepted: 18 May 2022

First Online: 10 June 2022

Declarations

:

: This work was supported by Vifor Pharma Switzerland.

: EB is an employee of HealthEcon, who was commissioned by Vifor Pharma Switzerland to conduct the analysis and prepare the first draft of this manuscript. OP reports consultant fees and or research grants from Vifor Pharma, Novartis, Pfizer, MSD, Astra Zeneca, Boehringer Ingelheim, Sanofi, and Bayer. GM reports consultant fees for taking part in advisory boards for Novartis, Bayer, Astra Zeneca, and Boehringer Ingelheim, outside of the submitted work.

: The analysis described in this manuscript is based on efficacy data based on published data, publicly available resource use, cost and epidemiological data, as well as a proprietary analysis of SwissDRG data. These have been described and referenced extensively in the methods section of this manuscript. The authors would be happy to respond to further enquiries regarding the details of the analysis should these not have been answered by the information provided in the methods section. The model used in this study was provided to the journal’s peer reviewers for their reference when reviewing the manuscript.

: The authors would be happy to respond to further enquiries regarding the details of the analysis should these not have been answered by the information provided in the methods section.

: All authors contributed to the conception of the work, validation of the input parameter values and drafting and revision of the manuscript.

: Ethics committee approval was not required for this study. In Switzerland, IRBs (i.e. cantonal/ hospital ethics commissions) are tasked with assessing research which falls under the Humanforschungsgesetz (Human Research Act; ). KOFAM (kofam.ch) is the Federal Office of Public Health’s (FOPH) portal for human research in Switzerland. KOFAM offers on its website the ‘categorizer’, a tool set up to help researchers ascertain whether their research project needs to be assessed by an ethics committee: . As the work presented here at no point in time touched on any individual or non-anonymized patient data, nor on any of the other topics covered by the Human Research Act, the Human Research Act does not apply to the work presented here, and hence ethics committee approval was not required.

: The analysis presented here was not based on individual or non-anonymized patient data. The authors would like to thank patients whose aggregated, anonymized clinical trial, registry, and SwissDRG data served as the basis for deriving the parameter input values for the analysis presented here.

: Not applicable.